Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease (vol 14, 1243505, 2023)

被引:0
作者
Lin, Weiwei [1 ,2 ]
Mousavi, Fatemeh [1 ]
Blum, Benjamin C. [1 ,2 ]
Heckendorf, Christian F. [1 ,2 ]
Moore, Jarrod [1 ,2 ]
Lampl, Noah [1 ,2 ]
McComb, Mark [1 ,2 ]
Kotelnikov, Sergei [3 ]
Yin, Wenqing [4 ]
Rabhi, Nabil [2 ]
Layne, Matthew D. [2 ]
Kozakov, Dima [3 ]
Chitalia, Vipul C. [4 ,5 ,6 ]
Emili, Andrew [1 ,2 ,7 ]
机构
[1] Boston Univ, Ctr Network Syst Biol, Boston, MA 02215 USA
[2] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02215 USA
[3] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY USA
[4] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA USA
[5] Vet Affairs Boston Healthcare Syst, Boston, MA USA
[6] MIT, Inst Med Engn & Sci, Cambridge, MA USA
[7] Boston Univ, Dept Biol, Boston 02215, MA USA
基金
加拿大健康研究院;
关键词
metabolomics; proteomics; nLC-MS/MS; ESKD; integrated omics;
D O I
10.3389/fphar.2024.1376058
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:2
相关论文
共 1 条
[1]   Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease [J].
Lin, Weiwei ;
Mousavi, Fatemeh ;
Blum, Benjamin C. ;
Heckendorf, Christian F. ;
Moore, Jarrod ;
Lampl, Noah ;
McComb, Mark ;
Kotelnikov, Sergei ;
Yin, Wenqing ;
Rabhi, Nabil ;
Layne, Matthew D. ;
Kozakov, Dima ;
Chitalia, Vipul C. ;
Emili, Andrew .
FRONTIERS IN PHARMACOLOGY, 2023, 14